Genentech
2025 ACHE Premier Corporate Partner

Over the past nearly 50 years, Genentech has embodied a pioneering spirit with a legacy of innovation across science and medicines. As founders of the biotechnology industry, we revolutionized treatment for some of the most complex health problems. Today, we continue to lead the industry—only our quest is bigger and bolder. As we look to the future, we remain dedicated to our rich history and spirit of scientific innovation and are evolving our quest to confront and overcome the most pressing health care challenges of our time.

But we know we cannot tackle these alone. By working together, we hope to solve some of the hardest biomedical challenges plaguing humankind.

On-Demand Webinar

Leading Through a Rapidly Evolving Healthcare Landscape

This webinar will feature senior healthcare leaders discussing their approaches to navigating the current shifts in healthcare. Participants will leave with new perspectives that they can incorporate in their own organizations. Faculty will tackle topics including the role of the patient as a consumer in health care, changes to care delivery models and technology. Specifically, they will discuss how leaders need to evolve their organizations to adapt to consumerism in healthcare, how leaders are leaning into changes and preparing their organizations to treat patients as new therapies emerge and how leaders are creating an environment where their people can adapt to these changes and utilize technology to better serve patients.

A Bold Ambition

In our quest to confront and overcome some of the most pressing health care challenges, we anticipate an increasingly complex health care landscape. Over the near term, we envision a number of challenges, 6 of which we find most relevant to healthcare executives: increasing disease burden, health care system pressures, decentralized care delivery, early detection, monitoring and intervention, access to health care and transformative technologies.

Like you, these challenges have a significant impact on our decision making. They shape the choices that we make as we embark on our ambition to confront and overcome some of the most pressing health care challenges and deliver 20 transformative medicines addressing diseases with the highest societal burden by 2030.

We Focus on Access So You Can Focus on Health

Genentech shares your commitment to advancing patient care and reducing barriers to treatment. From product information and patient access to screening initiatives, Genentech provides resources to help you and your patients, whether your focus is getting one patient on a Genentech therapy or on improving the entire patient population.

Our resources may be able to help health care providers, administrators and/or practice staff assist patients after a Genentech medicine has been prescribed.

Access

Back to Content Library ▲

Health Care System

Back to Content Library ▲

Screening

Back to Content Library ▲

Contact

Perin Registre
Executive Director, National Supply and Care Delivery
Genentech
954-234-0621
registre.perin@gene.com

Contact Us